CVS Health Corporation CVS posted second-quarter 2025 adjusted earnings per share (EPS) of $1.81, down 1.1% year over year. The metric topped the Zacks Consensus Estimate by 23.1%. The adjusted EPS ...
FY25 consensus $1.93. Backs FY25 revenue view $8.4B-$8.6B, consensus $8.56B. Cuts FY25 adjusted EBITDA view to $1.38B-$1.43B from $1.4B-$1.45B. The company remains confident in its $700M-$800M free ...
McKesson Corporation MCK reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $8.26, which beat the Zacks Consensus Estimate of $8.23 by 0.4%. The bottom line improved 4.8% on a ...
STERIS plc STE reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.47, up 15.4% from the year-ago quarter’s figure. The figure surpassed the Zacks Consensus Estimate by 3.8%.